EAM Investors’s Aceragen Inc ACGN Stock Holding History

EAM Investors’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-3,989	Closed	-$2.51M	–	365
2013 Q4	$2.51M	Buy	+3,989	New	+$1.33M	0.45%	54

Other funds holding ACGN

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

EAM Investors's ACGN Position: Q1 2014 in Review

EAM Investors sold out of Aceragen Inc (ACGN) in Q1 2014, closing a stake of 3,989 shares — an estimated $2.51M sold.

EAM Investors first reported a position in ACGN in Q4 2013 and held it in 1 quarter. The position peaked at $2.51M in Q4 2013. 67 funds tracked by Wall St. Rank hold ACGN as of Q1 2014.

EAM Investors reported no remaining Aceragen Inc position as of Q1 2014 after selling out during the quarter.
EAM Investors sold 3,989 Aceragen Inc shares in Q1 2014, an estimated $2.51M.
EAM Investors first reported a position in Aceragen Inc in Q4 2013 and held it in 1 quarter.
EAM Investors's Aceragen Inc position peaked at $2.51M in Q4 2013.
67 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2014.

Based on EAM Investors's 13F filing for Q1 2014, filed 15 May 2014.